News and Comments

Elan's Choices

  Saturday, April 16, 2011

Biogen Idec (BIIB) announced positive results of a process aimed at Identifying high-risk patients for a life-threatening side effect of prolonged use of the multiple sclerosis drug Tysabri. This test is a necessity because it detects an antibody that points to the presence of the Polyomavirus JC (JC virus), which causes the life-threatening progressive multifocal leukoencephalopathy (PML). This side effect in one per thousand patients has deprived Elan from billions of dollars in expected sales of Tysabri.  More...


Recent Postings


Archive


Tags

ISIS (ISIS) Cytokinetics (CYTK) C4 Therapeutics ABBVIE (ABBV) Multiple Myeloma ADVENTRIX (ANX) Anacor (ANAC) Sequenom (SQNM) Endometrial Cancer GlaxoSmithKline (GSK) Dynavax (DVAX) Valeant Pharmaceuticals International (VRX) JUNO (JUNO) Elan (ELN) galapagos (GLPG) Trastuzumab-DM1 GUARDIAN HEALTH Array Pharmaceuticals (ARRY) CompuGen (CGEN) Roche (RHHBY) Ridaforolimus ImmunoGen (IMGN) Alnylam (ALNY) Jazz Pharmaceuticals (JAZZ) Mirati Therapeutics (MRTX) Sanofi (SNA) Micromet (MITI) Biogen Idec (BIIB) Biocryst (BCRX) Xoma (XOMA) Ariad (ARIA) Ziofpharm (ZIOP) NANTKWEST (NK) RenenxBio (RGNX) Anadys (ANDS) HALOZYME (HALO) Human Genome Sciences (HGSI) Aimmune Therapeutics (AIMT) Roche (ROCHE) Herceptin Zerenex KERYX (KERX) Agenus (AGEN Genentech ARCA (ABIO) Seattle Genetics (SGEN) Galena (GALE) Sanofi (SNY) Theravance (THRX) Sanofi-Aventis (SAN) Tysabri Regeneron (REGN) Agenus (AGEN) Onyx (ONXX) BIOMARIN (BMRN) Vertex (VRTX) Merck (MRK) Benlysta (belimumab) Revlimid (lenolidamide) Rapamune Vitae Pharmaceuticals (VTAE) ACADIA (ACAD) Gilead (GILD) Auspex (ASPX) SYNTA (SNTA) Editas (EDIT) Prolor Biotech (PBTH) Sarepta (SRPT) Inovio (INO) Abbott Laboratories (ABT) SERES THERAPEUTICS (MCRB) Alder Biopharmaceuticals (ALDR) VANDA (VNDA) REGULUS (RGLS) Pluristem (PSTI) Telaprevir Incyte (INCY) NEKTAR (NKTR)) IDERA (IDRA) Intercept (ICPT) Human Longevity (HLI) Ionis (IONS) ZALTRAP™ Prosensa (RNA) PTC Therapeutics (PTCT) Intermune (ITMN) Intrexon (XON) Velcade (bortezomib) Theravance Bio Pharma (TBPH) KITE (KITE) AERIE PHARMACEUTICALS Idenix (IDIX) SUNESIS PHARMACEUTICALS (SNSS) Exelixis (EXEL) Amgen (AMGN) OSI (OSIP) Sangamo (SGMO) Illumina (ILMN) TOKAI (TKAOI) Bristol-Myers Squibb (BMY) Dendreon (DNDN)